Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates
Identifieur interne : 003460 ( Main/Exploration ); précédent : 003459; suivant : 003461Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates
Auteurs : Sara Cesarini [Italie] ; Andrea Spallarossa [Italie] ; Angelo Ranise [Italie] ; Paola Fossa [Italie] ; Paolo La Colla [Italie] ; Giuseppina Sanna [Italie] ; Gabriella Collu [Italie] ; Roberta Loddo [Italie]Source :
- Bioorganic & medicinal chemistry [ 0968-0896 ] ; 2008.
Descripteurs français
- Pascal (Inist)
- Antiviral, Chimie combinatoire, Composé benzénique, Composé non nucléoside, Cytotoxicité, In vitro, Inhibiteur enzyme, Inhibiteur reverse transcriptase, Modèle moléculaire, Modélisation, RNA-directed DNA polymerase, Relation structure activité, Résistance, Synthèse chimique, Thiocarbamate organique, Thiocarbamate(N-[4-chlorophényl]-O-[2-méthoxyphénéthyl]), Thiocarbamate(O-[3-méthoxyphénéthyl]-N-[4-nitrophényl]), Virus HIV1, Inhibiteur reverse transcriptase, Chimie combinatoire, Synthèse chimique, Modèle moléculaire, Modélisation, Relation structure activité, Thiocarbamate organique, In vitro, Dérivé de la pyridine, Dérivé du thiophène, Inhibiteur enzyme, Antiviral, RNA-directed DNA polymerase, Thiocarbamate(N-[3-nitrophényl]-O-[2-pyridyléthyl]), Thiocarbamate(N-[4-bromophényl]-O-[2-pyridyléthyl]).
English descriptors
- KwdEn :
- Antiviral, Benzenic compound, Chemical synthesis, Combinatorial chemistry, Cytotoxicity, Enzyme inhibitor, HIV-1 virus, In vitro, Modeling, Molecular model, Non nucleoside compound, Organic thiocarbamate, Pyridine derivatives, RNA-directed DNA polymerase, Resistance, Reverse transcriptase inhibitor, Structure activity relation, Thiophene derivatives.
Abstract
In order to expand the structure-activity relationship (SAR) studies on Thiocarbamates (TCs), a recently discovered class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors, 38 analogues of the lead O-[2-(2-pyridyl)ethyl]-N-phenylthiocarbamate 1 were prepared by parallel solution-phase synthesis. The SAR strategy was focused on the variation (mono- and disubstitution) of the N-phenyl ring and the replacement of the 2-pyridyl with 4-pyridyl, 2-thienyl and phenyl rings. The majority of the new TCs proved to prevent the wild-type HIV-1 multiplication in MT-4 cell culture and the most potent congeners displayed an EC50 value of 100 nM. Two TCs were active also at micromolar concentrations against the Y181C- and/or K103N/Y181C-resistant mutants. Docking simulations helped to rationalize the SARs.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000271
- to stream PascalFrancis, to step Curation: 000717
- to stream PascalFrancis, to step Checkpoint: 000238
- to stream Main, to step Merge: 003564
- to stream PascalFrancis, to step Corpus: 000270
- to stream PascalFrancis, to step Curation: 000718
- to stream PascalFrancis, to step Checkpoint: 000237
- to stream Main, to step Merge: 003563
- to stream Main, to step Curation: 003460
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates</title>
<author><name sortKey="Cesarini, Sara" sort="Cesarini, Sara" uniqKey="Cesarini S" first="Sara" last="Cesarini">Sara Cesarini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spallarossa, Andrea" sort="Spallarossa, Andrea" uniqKey="Spallarossa A" first="Andrea" last="Spallarossa">Andrea Spallarossa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ranise, Angelo" sort="Ranise, Angelo" uniqKey="Ranise A" first="Angelo" last="Ranise">Angelo Ranise</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fossa, Paola" sort="Fossa, Paola" uniqKey="Fossa P" first="Paola" last="Fossa">Paola Fossa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="La Colla, Paolo" sort="La Colla, Paolo" uniqKey="La Colla P" first="Paolo" last="La Colla">Paolo La Colla</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanna, Giuseppina" sort="Sanna, Giuseppina" uniqKey="Sanna G" first="Giuseppina" last="Sanna">Giuseppina Sanna</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Collu, Gabriella" sort="Collu, Gabriella" uniqKey="Collu G" first="Gabriella" last="Collu">Gabriella Collu</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Loddo, Roberta" sort="Loddo, Roberta" uniqKey="Loddo R" first="Roberta" last="Loddo">Roberta Loddo</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0345082</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0345082 INIST</idno>
<idno type="RBID">Pascal:08-0345082</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000271</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000717</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000238</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000238</idno>
<idno type="wicri:doubleKey">0968-0896:2008:Cesarini S:thiocarbamates:as:non</idno>
<idno type="wicri:Area/Main/Merge">003564</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0345092</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000270</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000718</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000237</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000237</idno>
<idno type="wicri:doubleKey">0968-0896:2008:Cesarini S:thiocarbamates:as:non</idno>
<idno type="wicri:Area/Main/Merge">003563</idno>
<idno type="wicri:Area/Main/Curation">003460</idno>
<idno type="wicri:Area/Main/Exploration">003460</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates</title>
<author><name sortKey="Cesarini, Sara" sort="Cesarini, Sara" uniqKey="Cesarini S" first="Sara" last="Cesarini">Sara Cesarini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spallarossa, Andrea" sort="Spallarossa, Andrea" uniqKey="Spallarossa A" first="Andrea" last="Spallarossa">Andrea Spallarossa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ranise, Angelo" sort="Ranise, Angelo" uniqKey="Ranise A" first="Angelo" last="Ranise">Angelo Ranise</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fossa, Paola" sort="Fossa, Paola" uniqKey="Fossa P" first="Paola" last="Fossa">Paola Fossa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV 3</s1>
<s2>16132 Genova</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>16132 Genova</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="La Colla, Paolo" sort="La Colla, Paolo" uniqKey="La Colla P" first="Paolo" last="La Colla">Paolo La Colla</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanna, Giuseppina" sort="Sanna, Giuseppina" uniqKey="Sanna G" first="Giuseppina" last="Sanna">Giuseppina Sanna</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Collu, Gabriella" sort="Collu, Gabriella" uniqKey="Collu G" first="Gabriella" last="Collu">Gabriella Collu</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Loddo, Roberta" sort="Loddo, Roberta" uniqKey="Loddo R" first="Roberta" last="Loddo">Roberta Loddo</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari, Cittadella Universitaria, S. S. 554, Km 4,500</s1>
<s2>09042 Monserrato (Cagliari)</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>09042 Monserrato (Cagliari)</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Bioorganic & medicinal chemistry</title>
<title level="j" type="abbreviated">Bioorg. med. chem.</title>
<idno type="ISSN">0968-0896</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Bioorganic & medicinal chemistry</title>
<title level="j" type="abbreviated">Bioorg. med. chem.</title>
<idno type="ISSN">0968-0896</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Benzenic compound</term>
<term>Chemical synthesis</term>
<term>Combinatorial chemistry</term>
<term>Cytotoxicity</term>
<term>Enzyme inhibitor</term>
<term>HIV-1 virus</term>
<term>In vitro</term>
<term>Modeling</term>
<term>Molecular model</term>
<term>Non nucleoside compound</term>
<term>Organic thiocarbamate</term>
<term>Pyridine derivatives</term>
<term>RNA-directed DNA polymerase</term>
<term>Resistance</term>
<term>Reverse transcriptase inhibitor</term>
<term>Structure activity relation</term>
<term>Thiophene derivatives</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiviral</term>
<term>Chimie combinatoire</term>
<term>Composé benzénique</term>
<term>Composé non nucléoside</term>
<term>Cytotoxicité</term>
<term>In vitro</term>
<term>Inhibiteur enzyme</term>
<term>Inhibiteur reverse transcriptase</term>
<term>Modèle moléculaire</term>
<term>Modélisation</term>
<term>RNA-directed DNA polymerase</term>
<term>Relation structure activité</term>
<term>Résistance</term>
<term>Synthèse chimique</term>
<term>Thiocarbamate organique</term>
<term>Thiocarbamate(N-[4-chlorophényl]-O-[2-méthoxyphénéthyl])</term>
<term>Thiocarbamate(O-[3-méthoxyphénéthyl]-N-[4-nitrophényl])</term>
<term>Virus HIV1</term>
<term>Inhibiteur reverse transcriptase</term>
<term>Chimie combinatoire</term>
<term>Synthèse chimique</term>
<term>Modèle moléculaire</term>
<term>Modélisation</term>
<term>Relation structure activité</term>
<term>Thiocarbamate organique</term>
<term>In vitro</term>
<term>Dérivé de la pyridine</term>
<term>Dérivé du thiophène</term>
<term>Inhibiteur enzyme</term>
<term>Antiviral</term>
<term>RNA-directed DNA polymerase</term>
<term>Thiocarbamate(N-[3-nitrophényl]-O-[2-pyridyléthyl])</term>
<term>Thiocarbamate(N-[4-bromophényl]-O-[2-pyridyléthyl])</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In order to expand the structure-activity relationship (SAR) studies on Thiocarbamates (TCs), a recently discovered class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors, 38 analogues of the lead O-[2-(2-pyridyl)ethyl]-N-phenylthiocarbamate 1 were prepared by parallel solution-phase synthesis. The SAR strategy was focused on the variation (mono- and disubstitution) of the N-phenyl ring and the replacement of the 2-pyridyl with 4-pyridyl, 2-thienyl and phenyl rings. The majority of the new TCs proved to prevent the wild-type HIV-1 multiplication in MT-4 cell culture and the most potent congeners displayed an EC<sub>50</sub>
value of 100 nM. Two TCs were active also at micromolar concentrations against the Y181C- and/or K103N/Y181C-resistant mutants. Docking simulations helped to rationalize the SARs.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Cesarini, Sara" sort="Cesarini, Sara" uniqKey="Cesarini S" first="Sara" last="Cesarini">Sara Cesarini</name>
</noRegion>
<name sortKey="Collu, Gabriella" sort="Collu, Gabriella" uniqKey="Collu G" first="Gabriella" last="Collu">Gabriella Collu</name>
<name sortKey="Fossa, Paola" sort="Fossa, Paola" uniqKey="Fossa P" first="Paola" last="Fossa">Paola Fossa</name>
<name sortKey="La Colla, Paolo" sort="La Colla, Paolo" uniqKey="La Colla P" first="Paolo" last="La Colla">Paolo La Colla</name>
<name sortKey="Loddo, Roberta" sort="Loddo, Roberta" uniqKey="Loddo R" first="Roberta" last="Loddo">Roberta Loddo</name>
<name sortKey="Ranise, Angelo" sort="Ranise, Angelo" uniqKey="Ranise A" first="Angelo" last="Ranise">Angelo Ranise</name>
<name sortKey="Sanna, Giuseppina" sort="Sanna, Giuseppina" uniqKey="Sanna G" first="Giuseppina" last="Sanna">Giuseppina Sanna</name>
<name sortKey="Spallarossa, Andrea" sort="Spallarossa, Andrea" uniqKey="Spallarossa A" first="Andrea" last="Spallarossa">Andrea Spallarossa</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:08-0345082 |texte= Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates }}
This area was generated with Dilib version V0.6.33. |